Health Care ETFs Have Lost In The Last Month – These Top Pharma Stocks Are The Reason
The Health Care Select Sector SPDR Fund (NYSE:XLV), heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies…
Raymond James Maintains Outperform on BridgeBio Pharma, Raises Price Target to $29
Raymond James analyst Dane Leone maintains BridgeBio Pharma (NASDAQ:BBIO) with a Outperform and raises the price target from $17 to $29.
Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors’ Attention Today
U.S. markets closed mixed on Monday as investors and traders turned their attention toward Federal Reserve Chair Jerome…
Why BioMarin Shares Are Plunging Today?
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday.
The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P 500 also rose, gaining, 0.35% to 4,059.80.
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.
The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500 also rose, gaining, 0.69% to 4,073.40.
BridgeBio’s Dwarfism Candidate Shows Favorable Height Increase, Safety Profile
BridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in children with achondroplasia, a genetic condition affecting a protein in the body called the fibroblast growth factor receptor.
What’s Going On With Kala Pharmaceuticals Shares Today
Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the day.
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.
BridgeBio Pharma Q4 EPS $(0.92) Misses $(0.86) Estimate, Sales $1.87M Miss $5.00M Estimate
BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.86) by 6.98 percent. This is a 8.91 percent increase over losses of $(1.01) per share from